Ethanol blocks nicotine-induced seizures in mice: comparison with midazolam and baclofen

Alcohol

Volumn 40, Issue 3, 2006, Pages 151-157

  Korkosz, Agnieszka ^a   Zatorski, Pawel ^a   Taracha, Ewa ^a   Plaznik, Adam ^a   Kostowski, Wojciech ^a   Bienkowski, Przemyslaw ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Baclofen; Blood ethanol levels; Ethanol; Locomotor activity; Mice; Midazolam; Nicotine; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; BACLOFEN; BENZODIAZEPINE RECEPTOR; MIDANIUM; MIDAZOLAM; NICOTINE; UNCLASSIFIED DRUG;

ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ALCOHOL INTERACTION; DRUG ANTAGONISM; EVALUATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; BACLOFEN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TONIC-CLONIC; ETHANOL; GABA AGENTS; MALE; MICE; MICE, INBRED C57BL; MIDAZOLAM; MOTOR ACTIVITY; NICOTINE;

MUS;

EID: 34047173630     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2006.12.001     Document Type: Article

References (47)

1. Aceto M.D. The antinicotinic effects of drugs with clinically useful sedative-antianxiety properties. Pharmacology 13 (1975) 458-464
2. Beleslin D.B., Jovanovic-Micic D., Nikolic S.B., and Samardzic R. Selective effect of ethanol on norepinephrine- and nicotine-induced emesis in cats. Alcohol 8 (1991) 499-501
3. Carai M.A., Brunetti G., Lobina C., Serra S., Vacca G., Minardi G., et al. Proconvulsive effect of the GABA(B) receptor antagonist, SCH 50911, in rats undergoing ethanol withdrawal syndrome. Eur J Pharmacol 445 (2002) 195-199
4. Cardoso R.A., Brozowski S.J., Chavez-Noriega L.E., Harpold M., Valenzuela C.F., and Harris R.A. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 289 (1999) 774-780
5. Clement J.G., and Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology 14 (1993) 485-504
6. Colombo G., Agabio R., Carai M.A., Lobina C., Pani M., Reali R., et al. Ability of baclofen in reducing alcohol intake and withdrawal severity. I. Preclinical evidence. Alcohol Clin Exp Res 24 (2000) 58-66
7. Covernton P.J., and Connolly J.G. Differential modulation of rat neuronal nicotinic receptor subtypes by acute application of ethanol. Br J Pharmacol 122 (1997) 1661-1668
8. Criswell H.E., and Breese G.R. A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology 30 (2005) 1407-1425
9. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Maciejak P., et al. Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. Eur J Pharmacol 425 (2001) 121-127
10. Damaj M.I., Glassco W., Dukat M., and Martin B.R. Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 291 (1999) 1284-1291
11. Dani J.A., and De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70 (2001) 439-446
12. De Fiebre C.M., and Collins A.C. Behavioral desensitization to nicotine is enhanced differentially by ethanol in long-sleep and short-sleep mice. Alcohol 6 (1989) 45-51
13. De Fiebre N.C., and De Fiebre C.M. α7 nicotinic acetylcholine receptor knockout selectively enhances ethanol-, but not β-amyloid-induced neurotoxicity. Neurosci Lett 373 (2005) 42-47
14. Dobelis P., Hutton S., Lu Y., and Collins A.C. GABAergic systems modulate nicotinic receptor-mediated seizures in mice. J Pharmacol Exp Ther 306 (2003) 1159-1166
15. Dundee J.W., Halliday N.J., Harper K.W., and Brogden R.N. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs 28 (1984) 519-543
16. Enna S.J. A GABA(B) mystery: the search for pharmacologically distinct GABA(B) receptors. Mol Interv 1 (2001) 208-218
17. Franceschini D., Paylor R., Broide R., Salas R., Bassetto L., Gotti C., et al. Absence of α7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Mol Brain Res 98 (2002) 29-40
18. Gasior M., Kaminski R., and Witkin J.M. Pharmacological modulation of GABA(B) receptors affects cocaine-induced seizures in mice. Psychopharmacology 174 (2004) 211-219
19. Gotti C., and Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74 (2004) 363-396
20. Grant K.A. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav Pharmacol 5 (1994) 383-404
21. Hansel D.E., Hansel C.R., Shindle M.K., Reinhardt E.M., Madden L., Levey E.B., et al. Oral baclofen in cerebral palsy: possible seizure potentiation?. Pediatr Neurol 29 (2003) 203-206
22. Howerton T.C., Marks M.J., and Collins A.C. Norepinephrine, gamma-aminobutyric acid, and choline reuptake kinetics and the effects of ethanol in long-sleep and short-sleep mice. Subst Alcohol Actions Misuse 3 (1982) 89-99
23. Kedmi M., Beaudet A.L., and Orr-Urtreger A. Mice lacking neuronal nicotinic acetylcholine receptor β4-subunit and mice lacking both α5- and β4-subunits are highly resistant to nicotine-induced seizure. Physiol Genomics 17 (2004) 221-229
24. Kim D.J.B., and Brioni J.D. Modulation of the discriminative stimulus properties of (-)-nicotine by diazepam and ethanol. Drug Dev Res 34 (1995) 47-54
25. Korkosz A., Taracha E., Plaznik A., Wrobel E., Kostowski W., and Bienkowski P. Extended blockade of the discriminative stimulus effects of nicotine with low doses of ethanol. Eur J Pharmacol 512 (2005) 165-172
26. Löscher W., Potschka H., Wlaz P., Danysz W., and Parsons C.P. Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats. Eur J Pharmacol 466 (2003) 99-111
27. Lovinger D.M. Alcohols and neurotransmitter gated ion channels: past, present and future. Naunyn Schmiedebergs Arch Pharmacol 356 (1997) 267-282
28. Marszalec W., Aistrup G.L., and Narahashi T. Ethanol-nicotine interactions at α-bungarotoxin-insensitive nicotinic acetylcholine receptors in rat cortical neurons. Alcohol Clin Exp Res 23 (1999) 439-445
29. McColl C.D., Horne M.K., Finkelstein D.I., Wong J.Y., Berkovic S.F., and Drago J. Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the α4 subunit of the neuronal nicotinic receptor. Neuropharmacology 44 (2003) 234-243
30. Mehta A.K., and Ticku M.K. Interactions of pentobarbital and phenobarbital with GABAergic drugs against chemoconvulsants in rats. Pharmacol Biochem Behav 30 (1988) 995-1000
31. Miner L.L., Marks M.J., and Collins A.C. Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sci 37 (1985) 75-83
32. Miner L.L., Marks M.J., and Collins A.C. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse. J Pharmacol Exp Ther 239 (1986) 853-859
33. Nagata K., Aistrup G.L., Huang C.S., Marszalec W., Song J.H., Yeh J.Z., et al. Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol. Neurosci Lett 217 (1996) 189-193
34. Narahashi T., Aistrup G.L., Marszalec W., and Nagata K. Neuronal nicotinic acetylcholine receptors: a new target site of ethanol. Neurochem Int 35 (1999) 131-141
35. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297 (2001) 646-656
36. Prasad A.N., and Seshia S.S. Status epilepticus in pediatric practice: neonate to adolescent. Adv Neurol 97 (2006) 229-243
37. Raines A., Henderson T.R., Swinyard E.A., and Dretchen K.L. Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia 31 (1990) 313-317
38. Salas R., Cook K.D., Bassetto L., and De Biasi M. The α3 and β4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47 (2004) 401-407
39. Schuele S.U., Kellinghaus C., Shook S.J., Boulis N., Bethoux F.A., and Loddenkemper T. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 64 (2005) 1086-1087
40. Serrano L., Capshaw B., and Quattrocchi F. A comparison of a microdiffusion method for ethanol and the Abbott TDx ethanol assay. J Anal Toxicol 12 (1988) 348-349
41. Stitzel J.A., Lu Y., Jimenez M., Tritto T., and Collins A.C. Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors. Behav Brain Res 113 (2000) 57-64
42. Tallarida R.J., and Murray R.B. Manual of Pharmacological Calculations. 2nd ed. (1987), Springer, New York
43. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., and Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3 (1989) 154-171
44. Van Rijckevorsel K., Boon P., Hauman H., Legros B., Ossemanns M., Sadzot B., et al. Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations. Acta Neurol Belg 105 (2005) 111-118
45. Wonnacott S., Sidhpura N., and Balfour D.J.K. Nicotine: from molecular mechanisms to behaviour. Curr Opin Pharmacol 5 (2005) 53-59
46. Wu G., Tonner P.H., and Miller K.W. Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor. Mol Pharmacol 45 (1994) 102-108
47. Zuo Y., Nagata K., Yeh J.Z., and Narahashi T. Single-channel analyses of ethanol modulation of neuronal nicotinic acetylcholine receptors. Alcohol Clin Exp Res 28 (2004) 688-696